What does DOKTERS CLAUS-GYSELBRECHT do?

DOKTERS CLAUS-GYSELBRECHT is a specialist medical practice in Aalst. Private Limited, started on 15 May 2002, 2 establishments.

What is the address of DOKTERS CLAUS-GYSELBRECHT?

The registered office of DOKTERS CLAUS-GYSELBRECHT is located at Varenlaan 21, 9300 Aalst.

Is DOKTERS CLAUS-GYSELBRECHT still active?

Yes. According to the CBE (29 October 2026) DOKTERS CLAUS-GYSELBRECHT is active, legal situation “Normale toestand”, started on 15 May 2002.

Is DOKTERS CLAUS-GYSELBRECHT registered on Peppol?

Yes, DOKTERS CLAUS-GYSELBRECHT is registered on the Peppol network with ID 0208:0477519023.

What is the enterprise number of DOKTERS CLAUS-GYSELBRECHT?

The enterprise number of DOKTERS CLAUS-GYSELBRECHT is BE0477519023.

When was DOKTERS CLAUS-GYSELBRECHT founded?

DOKTERS CLAUS-GYSELBRECHT was founded on 15 May 2002.

Who are the directors of DOKTERS CLAUS-GYSELBRECHT?

According to the 2026 annual accounts, the directors of DOKTERS CLAUS-GYSELBRECHT are: Bart Claus, Godelieve Gyselbrecht.

Is DOKTERS CLAUS-GYSELBRECHT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 May 2002; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did DOKTERS CLAUS-GYSELBRECHT make in 2026?

DOKTERS CLAUS-GYSELBRECHT posted a profit after taxes of € 277,312 in financial year 2026.

What is the revenue of DOKTERS CLAUS-GYSELBRECHT?

As a small company, DOKTERS CLAUS-GYSELBRECHT is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 344,307.

DOKTERS CLAUS-GYSELBRECHT (Private Limited) - Aalst

Dossier DOKTERS CLAUS-GYSELBRECHT, printed on 29 October 2026 from databakkes.be/en/0477519023/dokters-claus-gyselbrecht. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

DOKTERS CLAUS-GYSELBRECHT from Aalst, company number BE0477519023, closed financial year 2026 with a result of € 277,312 after tax. For that financial year DOKTERS CLAUS-GYSELBRECHT recorded a gross margin of € 344,307 and equity of € 1.9 million. Compared with financial year 2025, the result moved from € 297,232 to € 277,312. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.

What it is worth Growing

€ 1.9 million

▲ 3% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 277,312

▼ 7% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 237,994

▼ 38% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 223,294 paid out

81 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2026

Vehicles and equipment

€ 4,916

▼ 62% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

€ 5,297

▼ 57% vs 2025

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 5,924

▼ 14% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 54,817

▲ 25% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 434,671 Gross margin 2023: € 434,671 First fiscal year in the series	€ 513,247 Gross margin 2024: € 513,247 ▲ 18% vs 2023 (€ 434,671) Favourable step	€ 476,778 Gross margin 2025: € 476,778 ▼ 7% vs 2024 (€ 513,247) Unfavourable step	€ 344,307 Gross margin 2026: € 344,307 ▼ 28% vs 2025 (€ 476,778) Unfavourable step	▼ 28%
Profit after taxes	€ 160,595 Profit after taxes 2023: € 160,595 First fiscal year in the series	€ 314,377 Profit after taxes 2024: € 314,377 ▲ 96% vs 2023 (€ 160,595) Favourable step	€ 297,232 Profit after taxes 2025: € 297,232 ▼ 5% vs 2024 (€ 314,377) Unfavourable step	€ 277,312 Profit after taxes 2026: € 277,312 ▼ 7% vs 2025 (€ 297,232) Unfavourable step	▼ 7%
Equity	€ 1,632,757 Equity 2023: € 1,632,757 First fiscal year in the series	€ 1,727,135 Equity 2024: € 1,727,135 ▲ 6% vs 2023 (€ 1,632,757) Favourable step	€ 1,849,314 Equity 2025: € 1,849,314 ▲ 7% vs 2024 (€ 1,727,135) Favourable step	€ 1,903,332 Equity 2026: € 1,903,332 ▲ 3% vs 2025 (€ 1,849,314) Favourable step	▲ 3%
Total debts	€ 118,106 Total debts 2023: € 118,106 First fiscal year in the series	€ 332,300 Total debts 2024: € 332,300 ▲ 181% vs 2023 (€ 118,106) Unfavourable step	€ 66,524 Total debts 2025: € 66,524 ▼ 80% vs 2024 (€ 332,300) Favourable step	€ 115,322 Total debts 2026: € 115,322 ▲ 73% vs 2025 (€ 66,524) Unfavourable step	▲ 73%
Cash	€ 248,013 Cash 2023: € 248,013 First fiscal year in the series	€ 293,017 Cash 2024: € 293,017 ▲ 18% vs 2023 (€ 248,013) Favourable step	€ 386,915 Cash 2025: € 386,915 ▲ 32% vs 2024 (€ 293,017) Favourable step	€ 237,994 Cash 2026: € 237,994 ▼ 38% vs 2025 (€ 386,915) Unfavourable step	▼ 38%
Land & buildings	€ 16,089 Land & buildings 2023: € 16,089 First fiscal year in the series	€ 7,266 Land & buildings 2024: € 7,266 ▼ 55% vs 2023 (€ 16,089) Unchanged	€ 4,815 Land & buildings 2025: € 4,815 ▼ 34% vs 2024 (€ 7,266) Unchanged	€ 3,548 Land & buildings 2026: € 3,548 ▼ 26% vs 2025 (€ 4,815) Unchanged	▼ 26%
Retained profit	€ 1,626,557 Retained profit 2023: € 1,626,557 First fiscal year in the series	€ 1,720,935 Retained profit 2024: € 1,720,935 ▲ 6% vs 2023 (€ 1,626,557) Favourable step	€ 1,843,114 Retained profit 2025: € 1,843,114 ▲ 7% vs 2024 (€ 1,720,935) Favourable step	€ 1,897,132 Retained profit 2026: € 1,897,132 ▲ 3% vs 2025 (€ 1,843,114) Favourable step	▲ 3%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 220,000 Dividend 2024: € 220,000 Unchanged (€ 0) Unchanged	€ 175,052 Dividend 2025: € 175,052 ▼ 20% vs 2024 (€ 220,000) Unchanged	€ 223,294 Dividend 2026: € 223,294 ▲ 28% vs 2025 (€ 175,052) Unchanged	▲ 28%
Bank debt	€ 51,025 Bank debt 2023: € 51,025 First fiscal year in the series	€ 29,235 Bank debt 2024: € 29,235 ▼ 43% vs 2023 (€ 51,025) Favourable step	€ 12,299 Bank debt 2025: € 12,299 ▼ 58% vs 2024 (€ 29,235) Favourable step	€ 5,297 Bank debt 2026: € 5,297 ▼ 57% vs 2025 (€ 12,299) Favourable step	▼ 57%
Balance sheet total	€ 1,750,863 Balance sheet total 2023: € 1,750,863 First fiscal year in the series	€ 2,059,435 Balance sheet total 2024: € 2,059,435 ▲ 18% vs 2023 (€ 1,750,863) Unchanged	€ 1,915,838 Balance sheet total 2025: € 1,915,838 ▼ 7% vs 2024 (€ 2,059,435) Unchanged	€ 2,018,654 Balance sheet total 2026: € 2,018,654 ▲ 5% vs 2025 (€ 1,915,838) Unchanged	▲ 5%

Key figures of DOKTERS CLAUS-GYSELBRECHT, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to DOKTERS CLAUS-GYSELBRECHT?

What happened at DOKTERS CLAUS-GYSELBRECHT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 28, 2026 New annual accounts for financial year 2026: profit of € 277,312 (▼ 7% vs 2025). Source: NBB ↗
2022 Bart Claus became a director. NBB
2022 Godelieve Gyselbrecht became a director. NBB
May 24, 2002 New establishment in Aalst. KBO
May 24, 2002 New establishment in Aalst. KBO
May 15, 2002 Start of the company according to the CBE. KBO

In short

From € 160,595 profit in 2023 to € 277,312 profit in 2026.

Paid € 572,188 in corporate taxes since 2023.

Best year ever: 2024, with € 314,377 profit.

Paid out € 618,346 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bart Claus Godelieve Gyselbrecht

ORTHOPEDIE-TRAUMATOLOGIE AZORG

DOKTERS CLAUS-GYSELBRECHT

Behind DOKTERS CLAUS-GYSELBRECHT are Bart Claus and Godelieve Gyselbrecht. Bart Claus is also behind ORTHOPEDIE-TRAUMATOLOGIE AZORG.

Directors

According to the 2026 annual accounts

Bart Claus

Director

Also active at: ORTHOPEDIE-TRAUMATOLOGIE AZORG

since 2022

Godelieve Gyselbrecht

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Varenlaan 21

9300 Aalst

2.182.058.352

Merestraat 80

9300 Aalst

Active since 24 May 2002

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dienst Orthopedie ASZ

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0477.519.023

VAT number

BE 0477.519.023

Registered office

Varenlaan 21, 9300 Aalst

Names & denominations

DOKTERS CLAUS-GYSELBRECHT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 May 2002

Peppol

Active · Active since 27 Mar 2025

Activities · NACE

Activiteiten van medisch specialisten

Overige vormen van onderwijs

View on CBE Public ↗ Annual accounts (NBB) ↗

DOKTERS CLAUS-GYSELBRECHT

Financials

What happened to DOKTERS CLAUS-GYSELBRECHT?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions